Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocaliva
Pharma
FDA shoots down Intercept's bid for full approval of Ocaliva
In the wake of an unfavorable advisory committee meeting, Intercept's bid to win full approval for its liver disease drug Ocaliva has come up short.
Fraiser Kansteiner
Nov 12, 2024 2:12pm
Intercept's Ocaliva nod in danger after negative FDA adcomm vote
Sep 16, 2024 10:40am
Ocaliva's fate looks bleak after FDA releases new briefing docs
Sep 11, 2024 4:58pm
FDA approves Gilead's Livdelzi for primary biliary cholangitis
Aug 14, 2024 3:29pm
Alfasigma to take over struggling Intercept
Sep 26, 2023 11:10am
NASH market holds 'enormous untapped potential,' analysts say
Aug 10, 2023 10:00am
